Aptargroup, INC

AptarGroup announced its second quarter 2026 financial results, with reported sales surpassing $1 billion for the first time, driven by growth across all segments, particularly in Pharma and Closures.

AptarGroup, Inc. announced the appointment of Aditya J. Gandhi as Vice President, Chief Accounting Officer, effective June 8, 2026, succeeding Daniel Ackerman.

AptarGroup, Inc. announced the final voting results from its Annual Meeting of Stockholders, confirming the election of directors and approval of executive compensation and auditor ratification.

AptarGroup reported flat core sales for Q1 2026 and announced Gael Touya as the incoming CEO effective September 1, 2026.

AptarGroup, Inc. announced the retirement of CEO Stephan Tanda and the appointment of Gael Touya as his successor, effective September 1, 2026, alongside new compensation agreements and retention awards.

AptarGroup, Inc. announced its fourth quarter and annual 2025 results, showing increased sales but decreased net income in Q4, alongside a new $600 million share repurchase authorization.

AptarGroup reported Q1 2026 net sales of $982.9 million, reflecting 11% growth driven by acquisitions and currency effects, despite flat core sales.

AptarGroup, Inc. reported a significant increase in net income and EPS for Q3 2025, driven by a one-time gain from an equity investment remeasurement and a lower effective tax rate, alongside modest core sales growth.

AptarGroup, Inc. announced a significant increase in net income and earnings per share for the second quarter and first half of 2025, fueled by robust performance in its Pharma and Closures segments and effective cost management.

AptarGroup's Q1 2025 net sales decreased by 3% year-over-year, primarily due to unfavorable foreign currency exchange rates, though the Pharma segment showed strong growth.

AptarGroup's Q3 2024 results show a 2% increase in net sales, primarily driven by strong performance in the Pharma segment, while also announcing a new $500 million share repurchase program.

AptarGroup's second quarter results show a 2% increase in net sales and improved profitability, driven by strong performance in the Pharma segment.

AptarGroup, a global leader in dispensing and drug delivery solutions, reported a 5% increase in net sales to $3.78 billion for fiscal year 2025, driven by strong Pharma and Closures segment performance and strategic acquisitions.

AptarGroup's 2024 annual report reveals a 3% increase in both reported and core sales, reaching $3.58 billion, fueled by favorable product mix and volume growth.

AptarGroup, Inc. reports a 5% increase in net sales and a strategic realignment of its business segments in its annual 10-K filing.

Stephan B. Tanda, President and CEO and a Director of Aptargroup, Inc., sold 9,838 shares of common stock on August 3, 2026 for $136.16 per share.

Hedi Tlili, Segment President of Aptargroup, Inc., sold 8,854 shares of common stock on August 3, 2026 for $135.00 per share.

George L Fotiades, a Director of Aptargroup, Inc., received 151 shares of common stock on July 16, 2026.

Monnas Giovanna Kampouri, a Director of Aptargroup, Inc., received 151 shares of common stock on July 16, 2026.

Isabel Marey-Semper, a Director of Aptargroup, Inc., received 151 shares of common stock on July 16, 2026.

Candace S. Matthews, a Director of Aptargroup, Inc., received 226 shares of common stock on July 16, 2026.

AptarGroup's 2026 proxy statement details executive leadership changes, director elections, executive compensation, and corporate governance practices, including strong sustainability commitments.

AptarGroup files an amendment to its definitive proxy statement to correct the designation of its President and CEO, Stephan B. Tanda, as a non-independent director.

AptarGroup, Inc. announces its annual stockholder meeting to be held virtually on May 7, 2025, outlining key proposals for voting including the election of directors, executive compensation, and ratification of the accounting firm.

AptarGroup's 2025 proxy statement outlines key proposals for the annual meeting, including director elections, executive compensation approval, an equity incentive plan amendment, and ratification of the independent accounting firm, while also highlighting the company's commitment to sustainability and corporate governance.

AptarGroup, Inc. announces its annual stockholder meeting to be held virtually on May 1, 2024, outlining key proposals for shareholder voting.

AptarGroup, Inc. has released its proxy statement detailing the agenda and voting procedures for its upcoming annual meeting of stockholders on May 1, 2024.

Vanguard Capital Management has reported a beneficial ownership of 5.29% in AptarGroup Inc. common stock as of March 31, 2026.

Vanguard Portfolio Management has reported beneficial ownership of 5.92% of AptarGroup Inc.'s common stock as of March 31, 2026.

The Vanguard Group filed an amended Schedule 13G for AptarGroup Inc., reporting zero beneficial ownership following an internal realignment.

Morgan Stanley discloses a 6.1% beneficial ownership stake in AptarGroup Inc., holding over 4 million shares.